US Patent 7214850 Transgenic mouse expressing Prkag3
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+341 characters)
Article
Patent abstract
Transgenic non-human animals that express the γ3 subunit of PRKAG are described, as well as methods of using the transgenic non-human animals as models for improving treatment, prevention, or diagnosis of diseases related to energy metabolism, including obesity, dyslipidemia, insulin resistance syndrome, and type 2 diabetes.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07214850 Transgenic mouse expressing Prkag3 US Patent 7214850 Transgenic mouse expressing Prkag3
Infobox
Patent Number
0721485000
Patent Number
721485000
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072148500
Date of Patent
May 8, 2007
0Patent Application Number
105031750
Date Filed
January 31, 2003
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072148500
Date of Patent
May 8, 2007
0Patent Application Number
105031750
Date Filed
January 31, 2003
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07214850 Transgenic mouse expressing Prkag3
Infobox
Is a
Patent jurisdiction
Patent number
07214850
Date of patent
May 8, 2007
Patent application number
10503175
Date Filed
January 31, 2003
Patent primary examiner
Find more entities like US Patent 7214850 Transgenic mouse expressing Prkag3
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.